|
1
|
Sieminska I, Pieniawska M and Grzywa TM:
The immunology of psoriasis-current concepts in pathogenesis. Clin
Rev Allergy Immunol. 66:164–191. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ahmad A, Akhtar J, Ahmad M, Islam A,
Badruddeen, Khan MI, Siddiqui S and Srivastava A: Curcumin nanogel
preparations: A promising alternative for psoriasis treatment. Curr
Drug Metab. 25:179–187. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brunner SM, Ramspacher A, Rieser C,
Leitner J, Heil H, Ablinger M, Tevini J, Wimmer M, Koller A, Piñón
Hofbauer J, et al: Topical diacerein decreases skin and splenic
CD11c+ dendritic cells in psoriasis. Int J Mol Sci.
24:43242023. View Article : Google Scholar
|
|
4
|
Song Y, Zhao X, Qu H, Su Y, He R, Chen L,
Fang L, Li J, Zou Z, He J, et al: Epigenetic regulation of IL-23 by
E3 ligase FBXW7 in dendritic cells is critical for psoriasis-like
inflammation. J Immunol. 211:1701–1713. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mohanakrishnan R, Beier S and Deodhar A:
IL-23 inhibition for the treatment of psoriatic arthritis. Expert
Opin Biol Ther. 22:59–65. 2022. View Article : Google Scholar
|
|
6
|
Fiechter RH, de Jong HM, van Mens LJJ,
Fluri IA, Tas SW, Baeten DLP, Yeremenko NG and van de Sande MGH:
IL-12p40/IL-23p40 blockade with ustekinumab decreases the synovial
inflammatory infiltrate through modulation of multiple signaling
pathways including MAPK-ERK and Wnt. Front Immunol. 12:6116562021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carmona-Rocha E and Puig L: The biological
basis of disease recurrence in psoriasis. Ital J Dermatol Venerol.
158:279–291. 2023.PubMed/NCBI
|
|
8
|
Bubna AK and Viplav V: Revisiting
risankizumab: A newer biologic drug in dermatology. Ital J Dermatol
Venerol. 159:543–554. 2024.PubMed/NCBI
|
|
9
|
Megna M, Lauletta G, Tommasino N, Salsano
A, Battista T, Ruggiero A, Martora F and Potestio L: Management of
psoriasis patients with serious infectious diseases. Adv Ther.
41:2099–2111. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng YJ, Wang XX, Zhuang PY, Zhang DY, Gao
L, Chen JM and Han G: Study on chemical constituents of Codonopsis
pilosula. Zhongguo Zhong Yao Za Zhi. 42:135–139. 2017.In Chinese.
PubMed/NCBI
|
|
11
|
Yue J, Xiao Y and Chen W: Insights into
genus codonopsis: From past achievements to future perspectives.
Crit Rev Anal Chem. 54:3345–3376. 2024. View Article : Google Scholar
|
|
12
|
Hu J, Wang D, Wang F and Lin P: Lobetyolin
suppresses the proliferation of hepatocellular carcinoma through
activating DUSP1-ERK1/2 signaling pathway. Biol Pharm Bull.
47:1751–1758. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Z, Su Y, Ding J, He J, Lai L and Song
Y: Lobetyolin protects mice against LPS-induced sepsis by
downregulating the production of inflammatory cytokines in
macrophage. Front Pharmacol. 15:14051632024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Liu X, Wei W, Yang J, Li Q, Chu S,
Liu P, Zhang J and He W: Regulation of oxygen-glucose
deprivation/reperfusion-induced inflammatory responses and M1-M2
phenotype switch of BV2 microglia by lobetyolin. Metab Brain Dis.
38:2627–2644. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang W, He R, Qu H, Lian W, Xue Y, Wang T,
Lin W, Zhu P, Xia M, Lai L and Wang Q: FXYD3 enhances IL-17A
signaling to promote psoriasis by competitively binding TRAF3 in
keratinocytes. Cell Mol Immunol. 20:292–304. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Domingo-Almenara X and Siuzdak G:
Metabolomics data processing using XCMS. Methods Mol Biol.
2104:11–24. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Francis L, Capon F, Smith CH, Haniffa M
and Mahil SK: Inflammatory memory in psoriasis: From remission to
recurrence. J Allergy Clin Immunol. 154:42–50. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Katsiaunis A and Lipner SR: Devices for
treatment of nail psoriasis. Ital J Dermatol Venerol. 159:561–565.
2024.PubMed/NCBI
|
|
20
|
Mrowietz U, Lauffer F, Sondermann W,
Gerdes S and Sewerin P: Psoriasis as a systemic disease. Dtsch
Arztebl Int. 121:467–472. 2024.PubMed/NCBI
|
|
21
|
Hou YY, Qi SM, Leng J, Shen Q, Tang S,
Zhang JT, Hu JN, Jiang S and Li W: Lobetyolin, a Q-marker isolated
from radix platycodi, exerts protective effects on
cisplatin-induced cytotoxicity in HEK293 cells. J Nat Med.
77:721–734. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bailly C: Anticancer properties of
lobetyolin, an essential component of radix codonopsis (Dangshen).
Nat Prod Bioprospect. 11:143–153. 2021. View Article : Google Scholar :
|
|
23
|
Ni SH, OuYang XL, Liu X, Lin JH, Li Y, Sun
SN, Deng JP, Han XW, Zhang XJ, Li H, et al: A molecular phenotypic
screen reveals that lobetyolin alleviates cardiac dysfunction in
5/6 nephrectomized mice by inhibiting osteopontin. Phytomedicine.
107:1544122022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kouris A, Platsidaki E, Kouskoukis C and
Christodoulou C: Psychological parameters of psoriasis.
Psychiatriki. 28:54–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cohen E, Johnson CN, Wasikowski R, Billi
AC, Tsoi LC, Kahlenberg JM, Gudjonsson JE and Coulombe PA:
Significance of stress keratin expression in normal and diseased
epithelia. iScience. 27:1088052024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Romashin DD, Tolstova TV, Varshaver AM,
Kozhin PM, Rusanov AL and Luzgina NG: Keratins 6, 16, and 17 in
health and disease: A summary of recent findings. Curr Issues Mol
Biol. 46:8627–8641. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kircik L, Alexis AF, Andriessen A,
Blattner C, Glick BP, Lynde CW and Gold LS: Psoriasis and skin
barrier dysfunction: The role of gentle cleansers and moisturizers
in treating psoriasis. J Drugs Dermatol. 22:773–778. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Graubard R, Perez-Sanchez A and Katta R:
Stress and skin: An overview of mind body therapies as a treatment
strategy in dermatology. Dermatol Pract Concept. 11:e20210912021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Niehues H, Tsoi LC, van der Krieken DA,
Jansen PAM, Oortveld MAW, Rodijk-Olthuis D, van Vlijmen IMJJ,
Hendriks WJAJ, Helder RW, Bouwstra JA, et al: Psoriasis-associated
late cornified envelope (LCE) proteins have antibacterial activity.
J Invest Dermatol. 137:2380–2388. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Coto E, Santos-Juanes J, Coto-Segura P,
Díaz M, Soto J, Queiro R and Alvarez V: Mutation analysis of the
LCE3B/LCE3C genes in psoriasis. BMC Med Genet. 11:452010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Utsunomiya A, Chino T, Utsunomiya N, Luong
VH, Tokuriki A, Naganuma T, Arita M, Higashi K, Saito K, Suzuki N,
et al: Homeostatic function of dermokine in the skin barrier and
inflammation. J Invest Dermatol. 140:838–849.e9. 2020. View Article : Google Scholar
|
|
32
|
Solis ER and Jameson JM: Skin deep:
Epithelial cell metabolism and chronic skin inflammation. Immunity.
57:1451–1453. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Simard M, Morin S, Ridha Z and Pouliot R:
Current knowledge of the implication of lipid mediators in
psoriasis. Front Immunol. 13:9611072022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Simard M, Tremblay A, Morin S, Martin C,
Julien P, Fradette J, Flamand N and Pouliot R: α-Linolenic acid and
linoleic acid modulate the lipidome and the skin barrier of a
tissue-engineered skin model. Acta Biomater. 140:261–274. 2022.
View Article : Google Scholar
|
|
35
|
Hu X, Que W, Hirano H, Wang Z, Nozawa N,
Ishii T, Ishizuka M, Ito H, Takahashi K, Nakajima M, et al:
5-Aminolevulinic acid/sodium ferrous citrate enhanced the antitumor
effects of programmed cell death-ligand 1 blockade by regulation of
exhausted T cell metabolism in a melanoma model. Cancer Sci.
112:2652–2663. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kristensen S, Schmidt EB, Schlemmer A,
Rasmussen C, Johansen MB and Christensen JH: Beneficial effect of
n-3 polyunsaturated fatty acids on inflammation and analgesic use
in psoriatic arthritis: A randomized, double blind,
placebo-controlled trial. Scand J Rheumatol. 47:27–36. 2018.
View Article : Google Scholar
|
|
37
|
Łuczaj W, Gęgotek A and Skrzydlewska E:
Analytical approaches to assess metabolic changes in psoriasis. J
Pharm Biomed Anal. 205:1143592021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kamata M and Tada Y: Crosstalk:
Keratinocytes and immune cells in psoriasis. Front Immunol.
14:12863442023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim H, Choi MR, Jeon SH, Jang Y and Yang
YD: Pathophysiological roles of ion channels in epidermal cells,
immune cells, and sensory neurons in psoriasis. Int J Mol Sci.
25:27562024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wagner N and Wagner KD: The role of PPARs
in disease. Cells. 9:23672020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wagner N and Wagner KD: Recent insights
into the role of PPARs in disease. Cells. 12:15722023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li XF, Yin SQ, Li H, Yang YL, Chen X, Song
B, Wu S, Wu YY, Wang H and Li J: PPAR-γ alleviates the inflammatory
response in TNF-α-induced fibroblast-like synoviocytes by binding
to p53 in rheumatoid arthritis. Acta Pharmacol Sin. 44:454–464.
2023. View Article : Google Scholar
|
|
43
|
Lin X, Meng X, Song Z and Lin J:
Peroxisome proliferator-activator receptor γ and psoriasis,
molecular and cellular biochemistry. Mol Cell Biochem.
477:1905–1920. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
An Y and Zhang Q, Ren Y, Yang S and Zhang
Q: BML-111 modulates and alleviates p38/MAPK signaling pathway and
Th1/Th2/Th17 cytokine response in murine psoriasis-like dermatitis.
Discov Med. 36:2026–2036. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Long Q, Ma T, Wang Y, Chen S, Tang S, Wang
T, Zhou Y, Xu K, Wan P and Cao Y: Orientin alleviates the
inflammatory response in psoriasis like dermatitis in BALB/c mice
by inhibiting the MAPK signaling pathway. Int Immunopharmacol.
134:1122612024. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Novoszel P, Holcmann M, Stulnig G, De Sa
Fernandes C, Zyulina V, Borek I, Linder M, Bogusch A, Drobits B,
Bauer T, et al: Psoriatic skin inflammation is promoted by
c-Jun/AP-1-dependent CCL2 and IL-23 expression in dendritic cells.
EMBO Mol Med. 13:e124092021. View Article : Google Scholar : PubMed/NCBI
|
